Enfusion announced that on January 9, 2023, its Board of Directors had appointed Michael Spellacy, as Board Chair, effective immediately. "We are delighted with the addition of Michael Spellacy and are fortunate to have a leader with Mr. Spellacy’s strategic experience as our next Board chair. We look forward to benefiting from Michael’s deep understanding of our clients’ business requirements, and his familiarity with investment management technology. I can’t think of a more suitable candidate to lead the Board going forward," said Kathleen DeRose, Interim Chair of the Board, on behalf of the Board of Directors. "With our recent executive leadership transitions in place, the company is well-positioned to advance our strategy, execute on our plans, and focus on delivering even greater value for our stakeholders." Spellacy joins existing board directors Brad Bernstein, Roy Luo, Larry Leibowitz, Jan Hauser, Kathleen DeRose, Deirdre Somers, and Enfusion Chief Executive Officer, Oleg Movchan. Michael Spellacy is currently the Chief Executive Officer of Atlas Crest Investment Corporation and is globally recognized as an asset management and technology leader.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ENFN: